Lesson 2. Retreatment of Patients with Prior HCV Treatment Experience

Learning Objective Performance Indicators

  • Discuss the approach to retreatment of patients with chronic hepatitis C in the direct-acting antiviral (DAA) era
  • List the preferred therapeutic combinations for retreatment in persons with prior sofosbuvir-containing regimens
  • Describe recommended options for retreatment in persons with prior treatment with elbasvir-grazoprevir
  • Review preferred retreatment options for persons with prior treatment with glecaprevir-pibrentasvir
  • Summarize options for persons with multiple prior DAA treatment failures

About this Lesson

Learning Objective Performance Indicators

  • Discuss the approach to retreatment of patients with chronic hepatitis C in the direct-acting antiviral (DAA) era
  • List the preferred therapeutic combinations for retreatment in persons with prior sofosbuvir-containing regimens
  • Describe recommended options for retreatment in persons with prior treatment with elbasvir-grazoprevir
  • Review preferred retreatment options for persons with prior treatment with glecaprevir-pibrentasvir
  • Summarize options for persons with multiple prior DAA treatment failures

Share by e-mail

The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.